Cerus (CERS) Misses Q2 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Cerus Corporation Reports Second Quarter 2015 Results
August 6, 2015 4:01 PM EDTCONCORD, Calif.--(BUSINESS WIRE)-- Cerus Corporation (NASDAQ: CERS) today announced financial results for the second quarter ended June 30, 2015.
Recent company highlights include:
Second quarter disposable kit demand increased 32% year over year. Signed INTERCEPT platelet and plasma supply agreements with Unyts and Bonfils Blood Center. Suncoast Blood Bank produced the first INTERCEPT pathogen reduced platelet components distributed in the continental United States. Appointed Richard J. Benjamin, MD, PhD as chief medical officer. Received FDA approval of Phase IV PIPER study... More